Compare, Analyse Torrent Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

TORRENT PHARMA     Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
TORRENT PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,964376-   
Low Rs1,245271-   
Sales per share (Unadj.) Rs453.4111.7-  
Earnings per share (Unadj.) Rs25.8-28.1-  
Cash flow per share (Unadj.) Rs62.3-23.3-  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs279.287.7-  
Shares outstanding (eoy) m169.22168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.52.9 122.3%   
Avg P/E ratio x62.2-11.5 -541.9%  
P/CF ratio (eoy) x25.8-13.9 -185.9%  
Price / Book Value ratio x5.73.7 155.9%  
Dividend payout %65.90-   
Avg Mkt Cap Rs m271,51354,555 497.7%   
No. of employees `00013.64.3 316.7%   
Total wages/salary Rs m14,0383,424 410.0%   
Avg. sales/employee Rs Th5,642.64,392.1 128.5%   
Avg. wages/employee Rs Th1,032.4797.6 129.4%   
Avg. net profit/employee Rs Th320.9-1,106.7 -29.0%   
INCOME DATA
Net Sales Rs m76,72818,855 406.9%  
Other income Rs m571132 432.1%   
Total revenues Rs m77,29918,987 407.1%   
Gross profit Rs m19,831-3,267 -606.9%  
Depreciation Rs m6,177814 759.0%   
Interest Rs m5,038511 986.3%   
Profit before tax Rs m9,187-4,460 -206.0%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5700-   
Tax Rs m1,254279 449.8%   
Profit after tax Rs m4,363-4,751 -91.8%  
Gross profit margin %25.8-17.3 -149.1%  
Effective tax rate %13.6-6.2 -218.4%   
Net profit margin %5.7-25.2 -22.6%  
BALANCE SHEET DATA
Current assets Rs m50,37513,810 364.8%   
Current liabilities Rs m51,6537,770 664.8%   
Net working cap to sales %-1.732.0 -5.2%  
Current ratio x1.01.8 54.9%  
Inventory Days Days92111 83.0%  
Debtors Days Days68124 55.1%  
Net fixed assets Rs m83,6488,050 1,039.1%   
Share capital Rs m84688 966.6%   
"Free" reserves Rs m46,3970-   
Net worth Rs m47,24414,799 319.2%   
Long term debt Rs m39,1295,201 752.4%   
Total assets Rs m141,20927,957 505.1%  
Interest coverage x2.8-7.7 -36.5%   
Debt to equity ratio x0.80.4 235.7%  
Sales to assets ratio x0.50.7 80.6%   
Return on assets %6.7-15.2 -43.9%  
Return on equity %9.2-32.1 -28.8%  
Return on capital %12.3-19.8 -62.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m16,5810-   
CASH FLOW
From Operations Rs m17,9811,609 1,117.2%  
From Investments Rs m-2,413-494 488.3%  
From Financial Activity Rs m-13,1454,720 -278.5%  
Net Cashflow Rs m2,3805,835 40.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.18 Rs / ZAR

Compare TORRENT PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: AUROBINDO PHARMA  VENUS REMEDIES  STRIDES PHARMA SCIENCE  DR. DATSONS LABS  DISHMAN PHARMA  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

TORRENT PHARMA SHARE PRICE


May 7, 2021 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 5-YR ANALYSIS

COMPARE TORRENT PHARMA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS